Healthcare technology at UCSF is in full bloom. |
|
Moving MedTech to Market
Through Entrepreneurship in Nature
|
|
Biotech Startups Benefit Society by Solving Unmet Scientific and medical needs |
|
Innovation Ventures Managing Director of Entrepreneurship Stephanie Marrus, in collaboration with City University, New York economics professor John A. Blaho, authored an article in Nature that argues the private sector has mechanisms and expertise that can solve some of the funding difficulties that constrain the advancement of science in the pursuit of quality medical technologies.
Her appearance in the prestigious science periodical builds on her achievements as an educator of entrepreneurship, worldwide.
|
|
|
|
Global Life Sciences/Healthcare Entrepreneurship Course |
We are enrolling the 5th cohort of our acclaimed 10-week global online class, Global Life Sciences/Healthcare Entrepreneurship Course - Virtual Master Class Direct from Silicon Valley.
Learn the fundamentals you need to start a medical or science-based venture. The class is led by UCSF's Entrepreneurship Program and features guest lecturers from Silicon Valley.
We are the only live, virtual, open class that is life sciences and healthcare startup-focused, has the Silicon Valley mindset, and is global in scope.
|
|
|
|
Sign up for our 2023 Fall cohort now! |
|
In Conversation with Arun Wiita, PhD, Awardee |
|
Roopa Ramamoorthi, director of the InVent Fund, joins in conversation with Arun Wiita in conversation about his immunotherapy research into treating acute lymphoblastic leukemia. |
|
The University of California and Foundery Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies |
|
The University of California, San Francisco and Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, announced the signing of a five-year master agreement to collaborate on the translation of scientific discoveries in immunology by UCSF scientists into drug development candidates to treat diseases caused by immune system dysfunction.
The partnership is designed to support UCSF investigator research and create opportunities to develop and commercialize immunotherapeutics. Selected researchers will have access to Foundery’s preclinical drug discovery infrastructure. The master agreement is designed to enhance collaboration and develop impactful therapeutics between UCSF, participating scientists, and Foundery.
|
|
PICI Symposium Brings Cancer
Investigators Together at Mission Bay
|
|
On March 3rd, UCSF Innovation Ventures, in collaboration with Gladstone Institutes and Stanford Medicine, brought together top Parker Institute for Cancer Immunotherapy (PICI) researchers, to share their newest innovations in cancer treatment.
Organized by UCSF's Stacie Dodgson, PhD and Kole Roybal, PhD, and Stanford's Ansuman Satpathy, MD, PhD, the day consisted of three key segments that define the work all these academics are doing with PICI, Genomic Dissection of Tumor Immunology, Targeting Cytokines & Cell-Cell Interactions, and Cellular Immunotherapy Innovations.
|
|
Keynote Speakers
Christine Brown, PhD
Deputy Director, T Cell Therapeutics Research Laboratory;
Professor, Departments of Hematology
& Hematopoietic Cell Transplantation
and Immuno-Oncology City of Hope
Yvonne Chen, PhD
Associate Professor; Co-Director,
Jonsson Comprehensive Cancer Center (JCCC)
Tumor Immunology Program
UCLA
|
|
Additional Speakers
Oscar Aguilar Alfaro, PhD, UCSF
Rosemary Akhurst, PhD, UCSF
Julia Carnevale, MD, Gladstone Institute
Howard Chang, MD, PhD, Stanford University
John Connolly, PhD, PICI
Justin Eyquem, PhD, Gladstone Institute
Chris Garcia, PhD, Stanford University
Hani Goodarzi, PhD, UCSF
Kelly Kersten, PhD, UCSF
Louai Labanieh, PhD, Stanford
Lewis Lanier, PhD, UCSF
Crystal Mackall, MD, Stanford
Alexander Marson, MD, PhD, UCSF
Karin Pelka, PhD, UCSF
Zachary Steinhart, PhD, Gladstone Institute
Jennifer Hamilton, PhD, UC Berkeley
|
|
UCSF Speakers Reach Record Numbers at 2023 Precision Medicine World Conference |
|
In collaboration with Innovation Ventures, UCSF Precision Medicine made a big impression at the 2023 Precision Medicine World Conference in Santa Clara, California.
The opening day kicked off with a first-time panel on “How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs" along with more than 32 UCSF-related speakers throughout the three-day conference.
|
|
Join the UCSF LaunchPad for a virtual workshop titled “Beyond Logos and Websites: Design Strategy for Healthcare, HealthTech, and Biotech Startups” with Robbie Nock, the Associate Vice President of Entrepreneurship and Professional Practice at ArtCenter College of Design. By the end of the workshop, participants will know how to apply the Design toolkit to their startups and create effective Design strategies that align with their business goals. |
|
UCSF Researchers Present In 'Science'
|
|
Long-term functional regeneration of radiation-damaged salivary glands through the delivery of a neurogenic hydrogel |
|
Patients battling certain forms of cancer may find their salivary glands are severely depleted after radiotherapy. With no regenerative therapies available, organ dysfunction is irreversible. UCSF professors Chelsea Bahney and Sarah Knox present in 'Science,' their research into neurogenic hydrogels to restore the epithelial organ structure and function that has extensive implications for human patients. |
|
UCSF StartUps in the News |
|
If you have not already... |
|
|
|
|
|
|
